Browse studies, page 18

Page 18 of 1,159, newest first. Search them all at once, ranked by relevance, in Evidence Hub.

• A Systematic Review and Meta-analysis of Prostatic Urethral Lift for Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia European Urology Open Science, 2020
• Prostate Artery Embolization (PAE) in the Treatment of Benign Prostatic Hyperplasia: A Case Series and Narrative Review Journal of Clinical Medicine, 2025
• Prostatic Artery Embolization versus Standard Surgical Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis European Urology Focus, 2019
• The double-decking method for rezūm water vapor therapy in benign prostatic hyperplasia: volumetric, functional, and dosimetric outcomes BMC Urology, 2026
• Transurethral water vapor therapy for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a cost-minimization and budget impact analysis from an Italian healthcare perspective Minerva urology and nephrology, 2022
• Transurethral Cylindrical Water Sac Prostate Enlargement Surgery for the Treatment of Small-Volume Benign Prostatic Hyperplasia: A Retrospective Analysis Annali italiani di chirurgia, 2024
• Comparative Study of the Efficacy and Tolerability of Palmex® (Roystonea regia Lipid Extract), Saw Palmetto, Finasteride and Tamsulosin in Patients with Benign Prostatic Hyperplasia Urology research & practice, 2024
• Short- to Mid-term Safety and Efficacy of Prostatic Artery Embolization Using N-Butyl Cyanoacrylate for Symptomatic Benign Prostatic Hyperplasia – A Single-center Experience Indian Journal of Vascular and Endovascular Surgery, 2025
• IP03-22 efficacy of rezum therapy in acute urinary retention DUE to benign prostatic hyperplasia: analysis of clinical outcomes and factors associated with treatment failure Journal of Urology, 2025
• Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence Clinical interventions in aging, 2009
• The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension Journal of neurology, 2017
• REVITALISE: A Large Observational Study Assessing the Safety and Effectiveness of Vardenafil in Men With Erectile Dysfunction and Metabolic Syndrome Sexual medicine, 2016
• A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual men Therapeutic advances in urology, 2013
• Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily Clinical interventions in aging, 2008
• Prevalence, Burden, and Treatment of Lower Urinary Tract Symptoms in Men Aged 50 and Older: A Systematic Review of the Literature SAGE open nursing, 2018
• A clinical review of HIV integrase strand transfer inhibitors (INSTIs) for the prevention and treatment of HIV-1 infection Retrovirology, 2022
• Udenafil for the treatment of erectile dysfunction Therapeutics and clinical risk management, 2014
• Contemporary Approaches to Modulating the Nitric Oxide-cGMP Pathway in Cardiovascular Disease Circulation research, 2017
• The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion Frontiers in immunology, 2020
• Lower urinary tract symptoms in men BMJ (Clinical research ed.), 2014
• Benign prostatic hyperplasia and lower urinary tract symptom guidelines Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2012
• Safety and efficacy of tamsulosin, alfuzosin or silodosin as monotherapy for LUTS in BPH - a double-blind randomized trial Central European journal of urology, 2017
• Advances in pharmacotherapy for the treatment of overactive bladder Current bladder dysfunction reports, 2019
• New medical treatments for lower urinary tract symptoms due to benign prostatic hyperplasia and future perspectives BMC urology, 2016
• Pharmacological and interventional treatment of benign prostatic obstruction: An evidence-based comparative review BJUI compass, 2021
• Association between inflammatory indexes and erectile dysfunction in U.S. adults: National Health and Nutrition Examination Survey 2001-2004 Sexual medicine, 2023
• Modern best practice in the management of benign prostatic hyperplasia in the elderly Therapeutic advances in urology, 2020
• The effect of pharmacotherapy on prostate volume, prostate perfusion and prostate-specific antigen (prostate morphometric parameters) in patients with lower urinary tract symptoms and benign prostatic obstruction. A systematic review and meta-analysis Central European journal of urology, 2021
• Application of hydrophilic polymers for the preparation of tadalafil solid dispersions: micromeritics properties, release and erectile dysfunction studies in male rats PeerJ, 2022
• Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users Journal of xenobiotics, 2023
• Overview of BPH: Symptom Relief with Dietary Polyphenols, Vitamins and Phytochemicals by Nutraceutical Supplements with Implications to the Prostate Microbiome International journal of molecular sciences, 2023
• Alfuzosin for the medical treatment of benign prostatic hyperplasia and lower urinary tract symptoms: a systematic review of the literature and narrative synthesis Therapeutic advances in urology, 2021
• Onychomycosis in Diabetics: A Common Infection with Potentially Serious Complications Life (Basel, Switzerland), 2025
• Safety and effectiveness of mirabegron in male patients with overactive bladder with or without benign prostatic hyperplasia: A Japanese post-marketing study Lower urinary tract symptoms, 2021
• Is Early Surgical Treatment for Benign Prostatic Hyperplasia Preferable to Prolonged Medical Therapy: Pros and Cons Medicina (Kaunas, Lithuania), 2021
• A Novel Insight into the Immune-Related Interaction of Inflammatory Cytokines in Benign Prostatic Hyperplasia Journal of clinical medicine, 2023
• Established and emerging treatments for diabetes-associated lower urinary tract dysfunction Naunyn-Schmiedeberg's archives of pharmacology, 2022
• Effects of a proprietary mixture of extracts from Sabal serrulata fruits and Urtica dioica roots (WS® 1541) on prostate hyperplasia and inflammation in rats and human cells Frontiers in pharmacology, 2024
• A comparative study of Silodosin vs. Tamsulosin in the management of Benign Prostatic Hyperplasia: Outcomes in a tertiary care setting in Karachi International Journal of Endorsing Health Science Research, 2024
• Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial Research and Reports in Urology, 2018
• Clinical guidance and expert opinion on the use of prostatic urethral lift implants for benign prostatic hyperplasia Expert Review of Medical Devices, 2026
• Evaluation of the Effect of the oral Formulation Prepared from the Extract of Pomegranate Peel for the Treatment of Benign Prostate Hyperplasia: A Triple-Blind Randomized Clinical Trial Pharmaceutical Sciences, 2025
• Pharmacology, efficacy and safety of different extracts of Serenoa repens in patients with lower urinary tract symptoms and benign prostatic hyperplasia: a narrative review Minerva urology and nephrology, 2026
• Xia Li Qi Capsules Improve Symptoms and Urodynamic Parameters in Patients With Benign Prostatic Hyperplasia: A Randomised Controlled Trial With Evidence of p38-JAK/STAT Axis Inhibition Archivos españoles de urología, 2026
• Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential Translational Andrology and Urology, 2026
• A Short Scale Trial to Study and Evaluate the Safety and Efficacy of a Herbal Composition; Verona Anti-BPH Capsule to Treat Benign Prostatic Hyperplasia in Men Older than 40 Years of Age 2020
• Exploring the Efficacy of the Traditional Chinese Medicine Compound Formulas Qianlong Shutong Formula in the Treatment of Benign Prostatic Hyperplasia Journal of modern pharmacology and pathology, 2024
• GreenLight HPS laser 120 W vs diode laser 300 W vaporization of the prostate for the treatment of benign prostatic hyperplasia in Japanese patients: A prospective, single‐center, randomized clinical trial Lower urinary tract symptoms, 2020
• Efficacy of Prunus africana, Urtica dioica and Epilobium angustifolium in patients with benign prostatic hyperplasia International Journal of Functional Nutrition, 2024
• Efficacy and Safety of Thermobalancing Therapy in Men with Lower Urinary Tract Symptoms / Benign Prostatic Hyperplasia was Confirmed by Clinical Trial 2016
• Randomised Clinical Trial of Prostatic Artery Embolisation Versus a Sham Procedure for Benign Prostatic Hyperplasia European Urology, 2019
• Oxidative Stress in Benign Prostatic Hyperplasia: Mechanisms, Clinical Relevance and Therapeutic Perspectives Diseases, 2025
• Impact of CYP3A4*22 Genetic Variant and Plasma microRNA mir-27b Expression Level on Silodosin Steady-State Concentration and Therapy Outcomes in Patients with Benign Prostatic Hyperplasia: A Prospective Observational Trial Pharmacy & Pharmacology, 2025
• Efficacy and Safety of Transurethral Columnar Balloon Dilation of the Prostate for the Treatment of Benign Prostatic Hyperplasia: A Multicenter Trial Computational and Mathematical Methods in Medicine, 2022
• (074) Rezum Therapy for Catheter-Dependent Patients With Benign Prostatic Hyperplasia: Clinical Outcomes and Predictors of Treatment Success Journal of Sexual Medicine, 2025
• Efficacy of silodosin vs tamsulosin in patients with benign prostatic hyperplasia: a double-blind randomized clinical trial International Journal of Applied Pharmaceutics, 2019
• The role of prostatic artery embolization in the management of benign prostatic enlargement in patients with chronic liver disease: a prospective single-center clinical trial The Egyptian Journal of Radiology and Nuclear Medicine, 2025
• One-Year Clinical Outcomes of Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia: A Single-Center Experience of 52 Patients Cureus, 2025
• (079) Predictors of Failed Trial of Void After Rezum Water Vapor Therapy for Benign Prostatic Hyperplasia Journal of Sexual Medicine, 2025
• Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results Journal of Urology, 2023
• Safety and Clinical Efficacy of Prostatic Artery Embolization in Patients with Indwelling Urinary Catheter for Benign Hyperplasia—A Multicenter Study Diagnostics, 2024
• Safety and Efficacy of Vibegron in Men With Overactive Bladder Symptoms on Pharmacotherapy for Benign Prostatic Hyperplasia: Results From the 28-Week Open-Label COURAGE Extension Trial Completing the 52-Week Phase 3 Evaluation JU Open Plus, 2026
• Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial African Journal of Urology, 2024
• A controlled clinical trial to evaluate the efficacy of Tilanala Kshara in the management of Vatashteela vis-a-vis Benign Prostatic Hyperplasia Journal of Ayurveda and Integrated Medical Sciences, 2022
• A prospective, single‐center, randomized clinical trial to evaluate the efficacy of three types of laser vaporization surgeries using a 180‐W GreenLight XPS laser, a 300‐W diode laser, and a 200‐W thulium laser for the treatment of benign prostatic hyperplasia Lower urinary tract symptoms, 2022
• The latest in clinical trial results of 5-alpha reductase inhibitors in combination regimens for benign prostatic hyperplasia Expert Opinion on Pharmacotherapy, 2025
• A Clinical Investigation to Determine the Safety and Efficacy of a Novel, Patented Prunus Domestica Extract in Benign Prostatic Hyperplasia (BPH) Functional Foods in Health and Disease, 2025
• MP09-12 a prospective multicenter clinical trial for efficacy of mobile uroflowmetry in treatment-naïve benign prostatic hyperplasia undergoing medical therapy: interim results Journal of Urology, 2024
• Efficacy of tamsulosin in patients with benign prostatic hyperplasia in terms of trial without catheter, a randomized control trial Journal of University Medical & Dental College, 2021
• Homoeopathic treatment for lower urinary tract symptoms in men with benign prostatic hyperplasia: an open randomized multicentric placebo controlled clinical trial International journal of high dilution research, 2021
• Randomized controlled trial on the efficacy of bladder training before removing the indwelling urinary catheter in patients with acute urinary retention associated with benign prostatic hyperplasia Scandinavian journal of urology, 2014
• Randomized, controlled trial of laser vs. bipolar plasma vaporization treatment of benign prostatic hyperplasia Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2017
• Single Versus Double Dose Tamsulosin for Patients with Moderate or Severe Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: Prospective Randomized Study The Egyptian Journal of Hospital Medicine, 2024
• Comparison of Diode Laser (980 nm) Enucleation vs Holmium Laser Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia: A Randomized Controlled Trial with 12-Month Follow-Up Journal of endourology, 2019
• Holmium Laser Enucleation vs Bipolar Plasmakinetic Enucleation of a Large Volume Benign Prostatic Hyperplasia: A Randomized Controlled Trial Journal of endourology, 2019
• The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia Journal of Urology, 2023
• PD24-03 efficacy and safety of afalaza in MEN with symptomatic benign prostatic hyperplasia at risk of progression: a multicenter, double-blind, placebo-controlled, randomized clinical trial Journal of Urology, 2019
• Efficacy and safety of Afalaza in men with symptomatic benign prostatic hyperplasia at risk of progression: a multicenter, double-blind, placebo-controlled, randomized clinical trial Central European Journal of Urology, 2018
• Plasma Kinetic Enucleation vs Holmium Laser Enucleation for Treating Benign Prostatic Hyperplasia: A Randomized Controlled Trial with a 3-Year Follow-Up Journal of endourology, 2021
• Holmium laser enucleation versus bipolar resection in the management of large‐volume benign prostatic hyperplasia: A randomized controlled trial International journal of urology, 2021
• Efficacy evaluation of Chinese herbal medicine, VGH-BPH1, for patients with benign prostatic hyperplasia: A randomized, double-blind, placebo-controlled, and crossover study Journal of the Chinese Medical Association, 2022
• Randomized Controlled Trial of Aquablation versus Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia: One-year Outcomes Urology, 2019
• Efficacy and Safety of Serenoa repens Extract Among Patients with Benign Prostatic Hyperplasia in China: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial Urology, 2019
• Efficacy of a polyherbal formulation in the management of benign prostatic hyperplasia: a randomized, controlled trial International Journal of Advances in Medicine, 2021
• Efficacy and Safety of Deep Acupuncture at Qugu Point (CV2) for Benign Prostatic Hyperplasia: Study Protocol for a Randomized Controlled Trial 2021
• PD08-13 efficacy of the urocross expander, a NON-permanent device, for treatment of benign prostatic hyperplasia (BPH): feasibility trial results Journal of Urology, 2025
• Bipolar resection versus enucleation of the prostate in management of benign prostatic hyperplasia patients with large-sized prostates: a prospective randomized controlled clinical trial BMC Urology, 2026
• Transurethral anatomical enucleation of the prostate using a 1470-nm diode laser (DiLEP) versus transurethral resection of the prostate (TURP) for large-volume benign prostatic hyperplasia: a prospective randomized controlled trial Lasers in Medical Science, 2026
• Comparative analysis of low-power versus high-power holmium laser enucleation of the prostate for symptomatic small-volume benign prostatic hyperplasia: a prospective randomized controlled trial Journal of International Medical Research, 2024
• Efficacy and Safety of Mirabegron and Tamsulosin Combination Therapy Compared to Tamsulosin Monotherapy for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Results of a Multicenter, Randomized, Double-Blind, Phase III Clinical Trial The World Journal of Men's Health, 2025
• Bladder Function and Safety of Vibegron in Men With Overactive Bladder Receiving Treatment for Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial Neurourology and Urodynamics, 2025
• Transcutaneous tibial nerve stimulation combined mirabegron therapy significantly improves benign prostatic hyperplasia and overactive bladder: a prospective randomized controlled trial American journal of translational research, 2025
• Efficacy and safety of pelvic floor magnetic stimulation combined with mirabegron in men with benign prostatic hyperplasia and overactive bladder in a prospective randomized controlled trial American journal of clinical and experimental urology, 2025
• Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial Journal of Urology, 2024
• Urtica Dioica Root Extract on Clinical and Biochemical Parameters in Patients with Benign Prostatic Hyperplasia, Randomized Controlled Trial Pakistan Journal of Biological Sciences, 2020
• Holmium Laser Enucleation Versus Bipolar Plasmakinetic Resection for Management of Lower Urinary Tract Symptoms in Patients with Large-Volume Benign Prostatic Hyperplasia: Randomized-Controlled Trial Journal of endourology, 2020
• Effects of tissue-cultured mountain ginseng (Panax ginseng CA Meyer) extract on male patients with erectile dysfunction Asian journal of andrology, 2009
• Efficacy of tadalafil in Egyptian and Turkish men with erectile dysfunction International journal of clinical practice, 2006
• Urox containing concentrated extracts of Crataeva nurvala stem bark, Equisetum arvense stem and Lindera aggregata root, in the treatment of symptoms of overactive bladder and urinary incontinence: a phase 2, randomised, double-blind placebo controlled trial BMC complementary and alternative medicine, 2018
• Mirabegron Add-On Therapy to Tamsulosin in Men with Overactive Bladder: Post Hoc Analyses of Efficacy from the MATCH Study Advances in therapy, 2021